Microbiome and pancreatic ductal adenocarcinoma - 20/04/21
pages | 6 |
Iconographies | 1 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Pancreatic ductal adenocarcinoma (PDAC) incidence and related-deaths are increasing worldwide. PDAC is characterized by poor prognosis due to late diagnosis, high metastatic capacity and resistance to therapy. This is partially due to its specific microenvironment, where the stroma is prominent over tumor cells. Besides the oral and gut microbiota, the intratumor microbiome, i.e. the bacterial and fungal microorganisms present within the tumor, was recently introduced as a new partner of the tumor microenvironment of PDAC modulating pancreatic carcinogenesis, intratumor immune infiltrates, and response to chemotherapy. In this review, we propose an overview of current knowledge about the roles of bacteria and fungi in PDAC development and biology, and discuss potential therapeutic implications.
Le texte complet de cet article est disponible en PDF.Abbreviations : 5FU, AUC, CAF, CFB group, CI, DNA, EPIC, FMT, FOLFIRINOX, HR, IPMN, K. pneumoniae, LPS, LTS, MBL, MDSC, MSI, OR, OS, PDAC, P. gingivalis, RNA, ROC, STS, TLR
Keywords : Dysbiosis, Fungi, Intratumor bacteria, Microbiota, Pancreatic cancer
Plan
Vol 45 - N° 2
Article 101589- mars 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?